An Enriched Environment Ameliorates Oxidative Stress and Olfactory Dysfunction in Parkinson's Disease with α-Synucleinopathy

被引:24
作者
Wi, Soohyun [1 ,2 ]
Lee, Jang Woo [3 ,4 ]
Kim, MinGi [1 ,2 ]
Park, Chang-Hwan [5 ]
Cho, Sung-Rae [1 ,2 ,6 ,7 ]
机构
[1] Yonsei Univ, Dept & Res Inst Rehabil Med, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea
[3] Yonsei Univ, Grad Sch Med, Seoul, South Korea
[4] Natl Hlth Insurance Serv Ilsan Hosp, Dept Phys Med & Rehabil, Goyang, South Korea
[5] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 04763, South Korea
[6] Yonsei Univ, Rehabil Inst Neuromuscular Dis, Coll Med, Seoul, South Korea
[7] Avison Biomed Res Ctr, Yonsei Stem Cell Res Ctr, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
enriched environment; olfactory dysfunction; Parkinson's disease; detoxification enzymes; oxidative stress; PARAOXONASE; 1; RISK-FACTORS; UDP-GLUCURONOSYLTRANSFERASES; DRUG-METABOLISM; ALCOHOL; MPTP; EXPRESSION; BRAIN; PON1; NEURODEGENERATION;
D O I
10.1177/0963689717742662
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Parkinson's disease (PD) features nonmotor symptoms such as olfactory dysfunction referred to as hyposmia, an initial sign of disease progression. Metabolic dysfunction can contribute to neurodegenerative diseases, and various xenobiotics and endogenous compounds are also involved in the pathogenesis of PD. Although aerobic exercise was found to induce preservation or improvement in olfactory function in PD patients in a recent study, the exact underlying mechanism for this effect is not clear. We aimed to investigate the influence of an enriched environment (EE) on olfactory dysfunction especially via metabolic pathways related to detoxification enzymes. Eight-month-old transgenic (Tg) PD mice that overexpress human A53T alpha-synuclein (alpha-syn) were randomly allocated to an EE or standard conditions for 2 mo. The buried food test showed that EE group had significantly improved olfactory function compared to the control group. Reverse transcription polymerase chain reaction (PCR) and real-time quantitative PCR showed that expression of the detoxification enzymes-cytochrome P450 family I subfamily A member 2, paraoxonase I, alcohol dehydrogenase I, UDP glucuronosyltransferase family 2 member AI complex locus, aldehyde oxidase homolog 2, and aldehyde glutathione peroxidase 6-was significantly increased in the olfactory bulb (OB) of the PD control group, but these enzymes were normalized in the EE group. Immunohistochemical staining of the OB showed that oxidative stress and nitrated alpha-syn were significantly increased in the control group but decreased in the EE group. In conclusion, we suggest that exposure to an EE decreases both oxidative stress and nitrated alpha-syn, resulting in normalized detoxification enzymes and amelioration of olfactory dysfunction.
引用
收藏
页码:831 / 839
页数:9
相关论文
共 50 条
[1]   Paraoxonase 1 Met-Leu 54 polymorphism is associated with Parkinson's disease [J].
Akhmedova, SN ;
Yakimovsky, AK ;
Schwartz, EI .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 184 (02) :179-182
[2]   Role of paraoxonase 1 (PON1) in organophosphate metabolism: Implications in neurodegenerative diseases [J].
Androutsopoulos, Vasilis P. ;
Kanavouras, Konstantinos ;
Tsatsakis, Aristidis M. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2011, 256 (03) :418-424
[3]   OLFACTORY FUNCTION IN PATIENTS WITH PARKINSONS-DISEASE [J].
ANSARI, KA ;
JOHNSON, A .
JOURNAL OF CHRONIC DISEASES, 1975, 28 (09) :493-497
[4]   Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease [J].
Anvret, Anna ;
Ran, Caroline ;
Westerlund, Marie ;
Gellhaar, Sandra ;
Lindqvist, Eva ;
Pernold, Karin ;
Lundstromer, Karin ;
Duester, Gregg ;
Felder, Michael R. ;
Galter, Dagmar ;
Belin, Andrea Carmine .
BEHAVIOURAL BRAIN RESEARCH, 2012, 227 (01) :252-257
[5]   PERMANENT NEUROLOGICAL DEFICITS DUE TO LITHIUM TOXICITY [J].
APTE, SN ;
LANGSTON, JW .
ANNALS OF NEUROLOGY, 1983, 13 (04) :453-455
[6]   The epidemiology of Parkinson's disease: risk factors and prevention [J].
Ascherio, Alberto ;
Schwarzschild, Michael A. .
LANCET NEUROLOGY, 2016, 15 (12) :1255-1270
[7]   Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease [J].
Carmine, A ;
Buervenich, S ;
Sydow, O ;
Anvret, M ;
Olson, L .
MOVEMENT DISORDERS, 2002, 17 (04) :764-766
[8]   TARGETING ALDEHYDE DEHYDROGENASE 2: NEW THERAPEUTIC OPPORTUNITIES [J].
Chen, Che-Hong ;
Batista Ferreira, Julio Cesar ;
Gross, Eric R. ;
Mochly-Rosen, Daria .
PHYSIOLOGICAL REVIEWS, 2014, 94 (01) :1-34
[9]   Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population [J].
Clarimon, J ;
Eerola, J ;
Hellström, I ;
Tienari, PJ ;
Singleton, A .
NEUROSCIENCE LETTERS, 2004, 367 (02) :168-170
[10]  
Coleman T, 1996, J PHARMACOL EXP THER, V277, P685